does semaglutide lose effectiveness (Ozempic® & Wegovy®) Before and After Results: Weight Loss Timelines (2026) The Data Are Clear: Patients

[3] It's important to note that tirzepatide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is therefore not recommended in these patients

Confirming with your plan administrator in advance saves you a reimbursement dispute later

Regardless of delivery route, clinical monitoring body composition, patient-reported outcomes, relevant laboratory markers is what confirms therapeutic effect

The step back Stepping back means returning to your previous, lower dose after an increase did not sit well

This panel specifically measures GLP-1 levels and can indicate whether exogenous GLP-1 receptor agonist activity is present